Loading
ArcticZymes Technologies ASA Stock: price and insider trades · Norway
No insider purchase over the last 90 days. The latest was filed 04 Dec 2025.
ArcticZymes Technologies ASA: what insiders have been doing
ArcticZymes Technologies ASA is a Technology company. Its directors and officers file their transactions with Oslo Børs. The last twelve months, up to 18 October 2026, brought 2 filings signed by 2 insiders.
The flow runs one way only: 1 insider bought (1 purchase) and nobody sold on the market. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
For context, the typical company on the same exchange (median of 257 companies) published 4 filings over the same period, against 2 filings here. Looking back to 2021, when coverage begins, insiders filed 3 purchases and 4 sales.
The last insider purchase was made public on 4 December 2025, 317 days ago.
Other companies in the same sector with recent insider buying flagged by our signals: Core Scientific, Inc./tx and Gitlab Inc. Source: insider filings from Oslo Børs. Past trades are no guide to future returns.
Insider Decl.
21
Thresholds
n/a
Buy Volume
€45
3 ops. · all time
Sell Volume
€1,677
4 ops. · all time
Who traded when
BuySaleJon Moys1 buy
Norwegian Securities Trading Act.1 buy
Since the insiders bought
- -5.3%Entry NOK 19.90 · Close 15 Oct 2026 NOK 18.85
- -30.9%Entry NOK 29.10 · Close at T+365 NOK 20.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 12,118 of 24,148 companies
51.5
score / 100
Value31
Quality72
FCF yld2.2%
Earn yld1.0%
EV/EBITDA47.1x
ROE4.6%
Gross mgn96%
Net mgn8.6%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NOK 19.65
Analyst consensus
1 analysts2.00/5
NOK 28.00Target NOK 28.00(+42%)NOK 28.00
Income statement
RevenueNOK 112.6M
Gross profitNOK 107.8M96% margin
EBITDANOK 21.4M19% margin
Net incomeNOK 9.7M11.5% margin
Valuation
PER (trailing)65.5x
PER (forward)36.8x
P/Book2.9x
Beta0.57
Balance sheet & cash
Market capNOK 1B
Total debtNOK 5.3M
Free Cash FlowNOK 22.2M
Debt / Equity5%
Profitability & ownership
ROE4.6%
ROA2.0%
% insiders17.4%
% institutions13.8%
Last declaration on 4 December 2025
Declarations21 total
@ €1.9163ShareXOSLOSLO:661195
Canonical exit: 4 Mar 2026 (T+90)
3.4 shares@ NOK 16.00100.0% of flowOptionXOSLOSLO:648299
@ €0.8772OptionXOSLOSLO:646366
5 shares@ NOK 13.90100.0% of flowOptionXOSLOSLO:631855
2 sharesShareXOSLOSLO:631697
7.66 shares@ NOK 13.2598100.0% of flowOptionXOSLOSLO:631630
5 shares@ NOK 14.00100.0% of flowOptionXOSLOSLO:631520
130 shares@ NOK 40.00100.0% of flowOptionXOSLOSLO:593164
@ €0.6959OptionXOSLOSLO:593092
10.044 shares@ NOK 42.3905100.0% of flowShareXOSLOSLO:581375
Canonical exit: 4 May 2023 (T+90)
2.129 shares@ NOK 79.30018.9% of flowOptionXOSLOSLO:566430
120 shares@ NOK 88.00100.0% of flowOptionXOSLOSLO:549065
@ €0.7873OptionXOSLOSLO:549009
20 shares@ NOK 85.1291.1% of flowOptionXOSLOSLO:533468
21 of 21 declarations
About ArcticZymes Technologies ASA
ArcticZymes Technologies ASA is a Norwegian company focused on the development and production of enzymes for biotechnological applications. It is listed on the XOSL market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
